StockData
Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc. (INBX) stock

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$69.06−5.12 (-6.90%)

Close on Nov 18, 2026Market cap $1.02BP/E –Yield –

Inhibrx Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Inhibrx Biosciences's total debt was $276.70M at Sep 30, 2026. For fiscal 2025 it was $100.56M. The highest annual figure on record is $206.97M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$100.56M–
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$206.97M–
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$3.56M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$276.70M+176.9%
Q2 FY2026Jun 30, 2026$176.29M+77.6%
Q1 FY2026Mar 31, 2026$174.99M+77.4%
Q4 FY2025Dec 31, 2025$100.56M–
Q3 FY2025Sep 30, 2025$99.92M–
Q2 FY2025Jun 30, 2025$99.28M–
Q1 FY2025Mar 31, 2025$98.65M-52.6%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$208.21M+5743.7%
Q4 FY2023Dec 31, 2023$206.97M–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$1.88M–
Q4 FY2019Dec 31, 2019$3.56M–

More Inhibrx Biosciences figures

See a number that looks wrong?